The opportunity for greater patient and public involvement and engagement in drug development and regulation

Olalekan Lee Aiyegbusi*, Samantha Cruz Rivera, Kathy Oliver, Elaine Manna, Phil Collis, Bellinda L. King-Kallimanis, Vishal Bhatnagar, Ralf Herold, Jon Hopkins, Lisa Campbell, Alysha Croker, Myles Leach, Melanie Calvert

*Corresponding author for this work

Research output: Contribution to journalComment/debate

31 Downloads (Pure)

Abstract

Patients and the wider public are beneficiaries of scientific research that leads to new drugs and medical technologies, but they can and should be able to contribute to these advances through participation in clinical studies, co-design of research and input into regulatory processes.
Original languageEnglish
Pages (from-to)337-338
Number of pages2
JournalNature reviews. Drug discovery
Volume22
Issue number5
Early online date28 Feb 2023
DOIs
Publication statusPublished - May 2023

Fingerprint

Dive into the research topics of 'The opportunity for greater patient and public involvement and engagement in drug development and regulation'. Together they form a unique fingerprint.

Cite this